Výsledky vyhledávání - "J. Berth‐Jones"

A randomised, controlled trial of a 4% cutaneous emulsion of sodium cromoglicate in treatment of atopic dermatitis in children

Autor: Pamela McHenry, R. M. Ross Hearn, J. Berth-Jones, Jennifer Ott, Andrew Wright, Anthony Abdullah, Mark Goodfield, Sue Lewis-Jones, Benjamin Walker, Ian Pollock, Ram Kumar Gulati, Christopher E.M. Griffiths, Michael T Stevens, Alan M. Edwards

Publikováno v: Journal of Dermatological Treatment. 26:291-296

Atopic dermatitis (AD) is a chronic inflammatory skin disease. Sodium cromoglicate (SCG) is a chromone with anti-inflammatory, anti-itch and anti-allergic activity. This trial is a 12-week comparison (RCT) of a 4% SCG cutaneous emulsion with its vehi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b7747872dba58c2a6e0cba703ad7d11
https://doi.org/10.3109/09546634.2014.946380

Zobrazit plný text záznamu

Human papillomavirus typing of warts and response to cryotherapy

Autor: J. Berth-Jones, I. Ahmed, J. Hague, J. Sterling, N. Tomson

Publikováno v: Journal of the European Academy of Dermatology and Venereology. 25:1108-1111

Background Cutaneous warts are common and caused by a number of different types of human papillomaviruses (HPVs). Objective The aim of this study was to investigate the HPV types causing common warts and to determine any association between the HPV t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e5356325b9580e152e88877785d97903
https://doi.org/10.1111/j.1468-3083.2010.03906.x

Zobrazit plný text záznamu

A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index

Autor: J, Berth-Jones, J, Thompson, K, Papp, Gottfried, Wozel

Publikováno v: British Journal of Dermatology. 159:407-412

BACKGROUND: There is a perceived need for a better method for clinical assessment of the severity of psoriasis vulgaris. The most frequently used system is the Psoriasis Area and Severity Index (PASI), which has significant disadvantages, including t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b97df71b1906e9d722befbd11f003ccc
https://doi.org/10.1111/j.1365-2133.2008.08680.x

Zobrazit plný text záznamu

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids

Autor: T. C. Brown, Gregor B.E. Jemec, Robert Bissonnette, Charles Lynde, M Harsch, Filippa Nyberg, Åke Svensson, J. Maares, P Hollo, Thomas L. Diepgen, Thomas Ruzicka, E. Varjonen, P.-J. Coenraads, Frédéric Cambazard, M Lahfa, J. Berth-Jones, Peter Elsner, A Kaszuba

Publikováno v: BRITISH JOURNAL OF DERMATOLOGY, 158(4), 808-817. Wiley

Background Patients with severe chronic hand eczema (CHE) refractory to topical corticosteroids currently have limited treatment options suited for chronic use, and few controlled clinical studies have investigated new therapies in this setting.Objec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9af0458dbc4330af4131dc34a69ef375
https://hdl.handle.net/11370/1fcb2ecc-5c91-4752-8e5e-9c8296b2effe

Zobrazit plný text záznamu

Scalp psoriasis: a review of current topical treatment options

Autor: Knud Kragballe, Gottfried Wozel, J. Berth-Jones, Kim A. Papp, M. de la Brassinne

Publikováno v: Journal of the European Academy of Dermatology and Venereology. 21:1151-1160

The scalp is the most common site of disease involvement at the onset and throughout the course of psoriasis. For many patients, psoriasis of the scalp is the most difficult aspect of their disease; yet, despite a wide range of therapy options and an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f5b03c50b6a4c54b8c147069c99deef3
https://doi.org/10.1111/j.1468-3083.2007.02424.x

Zobrazit plný text záznamu

A double-blind, placebo-controlled trial of montelukast in adult atopic eczema

Autor: Peter S. Friedmann, R. A. Palmer, K. Hotchkiss, M. Ogboli, J. Berth-Jones, G. Barclay, E. Tan

Publikováno v: Clinical & Experimental Allergy. 37:1536-1540

Background Montelukast is an antagonist of cys-leukotriene receptors used mainly in the treatment of asthma- and seasonal-allergic rhinitis. Initial reports concerning the use of montelukast in atopic dermatitis (AD) have been encouraging, although n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4bb3705e4aedaa80d767675f82e60a71
https://doi.org/10.1111/j.1365-2222.2007.02811.x

Zobrazit plný text záznamu

Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study

Autor: J. Jacovella, Thomas Ruzicka, Jürgen Schauber, P Briantais, Abdallah Khemis, J. Berth-Jones, Thierry Passeron, A. Taieb, Wioletta Barańska-Rybak

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV. 30(5)

Background There are a limited number of approved treatments for papulopustular rosacea (PPR) and remission is difficult to maintain after successful treatment. Objectives To investigate remission over a 36-week extension period in patients with mode

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a24bff0f4991e1820c0038b6d661725
https://pubmed.ncbi.nlm.nih.gov/26691278

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání